Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 34; no. 5; pp. 1524 - 1525
Main Authors Jain, A, Pokharna, R, Eghtesad, B, Potdar, S, Kashyap, R, Kingery, L, Fung, J
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2002
Elsevier Science
Subjects
Adrenal Cortex Hormones - administration & dosage
Adrenal Cortex Hormones - therapeutic use
Biological and medical sciences
Cholangitis, Sclerosing - surgery
Disease-Free Survival
Drug Administration Schedule
Drug Therapy, Combination
Follow-Up Studies
Hepatitis, Autoimmune - surgery
Humans
Immunomodulators
Immunosuppressive Agents - therapeutic use
Liver Cirrhosis, Biliary - surgery
Liver Function Tests
Liver Transplantation - immunology
Liver Transplantation - mortality
Liver Transplantation - physiology
Liver, biliary tract, pancreas, portal circulation, spleen
Medical sciences
Pharmacology. Drug treatments
Retrospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Survival Analysis
Tacrolimus - therapeutic use
Time Factors
Autoimmunity
Prognosis
Calcineurin inhibitor
Indication
Hepatic disease
Transplantation
Biliary cirrhosis
Biliary tract disease
Homotransplantation
Hepatitis
Surgery
Treatment withdrawal
Primary
Graft
Sclerosing cholangitis
Human
Corticosteroid
Treatment efficiency
Lactone
Long term
Macrolide
Survival
Chemotherapy
Treatment
Tacrolimus
Digestive diseases
Immunosuppressive agent
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(02)03004-X